金通靈(300091.SZ):簽訂3.09億元壓縮機產品重大經營合同
格隆匯11月3日丨金通靈(300091.SZ)公佈,公司與凱賽生物(688065.SH)旗下的控股子公司凱賽(太原)生物於2021年9月9日在山西省綜改示範區陽曲產業園區就凱賽(太原)生物“新建大型集中式壓縮空氣站項目”簽訂了《建設工程總承包合同》,簽約合同總額為3.09億元(含税)。項目由金通靈總承包建設,其中合同約定土建施工由凱賽(太原)生物負責。公司於2021年11月1日收到凱賽(太原)生物相關工程預付款6180萬元。
公司壓縮機產品的製造,引進了美國ETI技術,目前已具備國產化替代進口的能力。在國家推進雙碳雙控背景下,該合同的簽訂對公司未來的壓縮機產品和業務發展有積極意義。該合同中約定由金通靈總承包建設的項目包含了汽輪機拖動壓縮機系統、壓縮機節能型熱交換系統、熱回收溴化鋰製冷系統等三大高效節能系統。截止該公吿日,該合同是公司承接的壓縮機產品業務中金額最大、壓縮空氣氣量最大的大型集中式壓縮空氣站集成項目合同。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.